Peripheral decarboxylase inhibitor, used in combination with levodopa for treatment of Parkinsonism.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 226.23. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||4.42 mL||22.1 mL||44.2 mL|
|5 mM||0.88 mL||4.42 mL||8.84 mL|
|10 mM||0.44 mL||2.21 mL||4.42 mL|
|50 mM||0.09 mL||0.44 mL||0.88 mL|
References are publications that support the products' biological activity.
Kopfhammer et al (1985) L-Dopa infusion experiments in combination with the L-dopa decarboxylase inhibitors benserazide and carbidopa - L-dopa metabolism and neuroendocrinological effects. Pharmacopsychiatry 18 143 PMID:
If you know of a relevant reference for (S)-(-)-Carbidopa, please let us know.
View Related Products by Product Action
Keywords: (S)-(-)-Carbidopa, supplier, Aromatic, Lamino, acid, decarboxylase, inhibitors, inhibits, Decarboxylases, Dopaminergic-Related, Decarboxylases, Tocris Bioscience
Citations for (S)-(-)-Carbidopa
Citations are publications that use Tocris products.
Currently there are no citations for (S)-(-)-Carbidopa. Do you know of a great paper that uses (S)-(-)-Carbidopa from Tocris? If so please let us know.
Average Rating:(Based on 0 Reviews)